|
|
Volumn 104, Issue 14, 2012, Pages 1042-1043
|
|
Study supports PSA velocity risk count.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
AGE;
BLOOD;
DIFFERENTIAL DIAGNOSIS;
EVIDENCE BASED MEDICINE;
HUMAN;
IMMUNOLOGY;
MALE;
NOTE;
PROSTATE HYPERTROPHY;
PROSTATE TUMOR;
RISK ASSESSMENT;
RISK FACTOR;
UNNECESSARY PROCEDURE;
WATCHFUL WAITING;
AGE FACTORS;
DIAGNOSIS, DIFFERENTIAL;
EVIDENCE-BASED MEDICINE;
HUMANS;
MALE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC HYPERPLASIA;
PROSTATIC NEOPLASMS;
RISK ASSESSMENT;
RISK FACTORS;
TUMOR MARKERS, BIOLOGICAL;
UNNECESSARY PROCEDURES;
WATCHFUL WAITING;
|
|
EID: 84873051273
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djs324 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
